Erika Hamilton, Chief Development Officer, Late Phase and Director, Breast Cancer Research Program at Sarah Cannon Research Institute, shared on X, quotting to ESMO – Eur. Oncology’s post:
“ESMO26 LBA are out! You can fully plan your meeting! Calendars, walking time, breaks, and networking! ”
ESMO – Eur. Oncology shared on X:
“The late-breaking abstract lineup is taking shape! Authors and titles are online, and most of the submissions are already there. 30K+ delegates already registered from around the world, so this means new data, new insights and new opportunities to connect. Register now!”
ESMO Congress 2026: Registration.
You can also read ‘ESMO Targeted Anticancer Therapies (TAT) Congress 2027‘
